Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia

The main treatment for renal anemia in end-stage renal disease (ESRD) patients on hemodialysis is erythropoiesis (EPO). EPO hyporesponsiveness (EH) in dialysis patients is a common clinical problem, which is poorly understood. Recent searches reported that gut microbiota was closely related to the o...

Full description

Bibliographic Details
Main Authors: Yifan Zhu, Yuyan Tang, Haidong He, Ping Hu, Weiqian Sun, Meiping Jin, Lishun Wang, Xudong Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
gut microbiota
ESRD (End Stage Renal Disease)
Anemia
EPO hyporesponsiveness
hemodialysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.919352/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.919352/full

Similar Items